Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma (MERITS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00848640
Recruitment Status : Completed
First Posted : February 20, 2009
Last Update Posted : May 26, 2010
Information provided by:
Egyptian Foundation For Cancer Research

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2009
  Study Completion Date : March 2010